DNA–affibody nanoparticles for inhibiting breast cancer cells overexpressing HER2

2017 ◽  
Vol 53 (3) ◽  
pp. 573-576 ◽  
Author(s):  
Yanmin Zhang ◽  
Shuoxing Jiang ◽  
Dongdong Zhang ◽  
Xiaoguang Bai ◽  
Sidney M. Hecht ◽  
...  

A DNA tetrahedron–affibody–drug nanoparticle is a highly efficient tool to deliver doxorubicin (DOX) to HER2 overexpressing cancer cells specifically. It represents a highly efficacious agent for selectively inhibiting cancer cells which overexpress HER2 receptor.

2011 ◽  
Vol 91 (3) ◽  
pp. 613-621 ◽  
Author(s):  
Silvia Sommaruga ◽  
Alessio Lombardi ◽  
Agnese Salvadè ◽  
Serena Mazzucchelli ◽  
Fabio Corsi ◽  
...  

Marine Drugs ◽  
2015 ◽  
Vol 13 (1) ◽  
pp. 288-311 ◽  
Author(s):  
Mohamed Akl ◽  
Nehad Ayoub ◽  
Hassan Ebrahim ◽  
Mohamed Mohyeldin ◽  
Khaled Orabi ◽  
...  

2014 ◽  
Vol 38 (2) ◽  
pp. 155-164 ◽  
Author(s):  
Vassilis Papanikolaou ◽  
Nikolaos Stefanou ◽  
Stephanie Dubos ◽  
Ioanna Papathanasiou ◽  
Maria Palianopoulou ◽  
...  

2013 ◽  
Vol 49 (20) ◽  
pp. 2010 ◽  
Author(s):  
Kyoung-Ran Kim ◽  
Da-Rae Kim ◽  
Taemin Lee ◽  
Ji Young Yhee ◽  
Byeong-Su Kim ◽  
...  

2010 ◽  
Vol 34 (8) ◽  
pp. S49-S49
Author(s):  
Lei Wang ◽  
Xun Zhou ◽  
Lihong Zhou ◽  
Yong Chen ◽  
Xun Zhu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document